Laney Smith
Overview
Explore the profile of Laney Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wojcik K, Kamil D, Zhang J, Wilson O, Smith L, Butera G, et al.
J Cancer Surviv
. 2024 Mar;
PMID: 38538922
Purpose: We reviewed existing personalized, web-based, interactive decision-making tools available to guide breast cancer treatment and survivorship care decisions in clinical settings. Methods: The study was conducted using the Preferred...
2.
Kamil D, Wojcik K, Smith L, Zhang J, Wilson O, Butera G, et al.
MDM Policy Pract
. 2024 Mar;
9(1):23814683241236511.
PMID: 38500600
Highlights: There were 19 personalized, interactive, Web-based decision tools for breast cancer prevention and screening.Breast cancer outcomes were personalized based on individual clinical characteristics (e.g., age, medical history), genomic risk...
3.
Smith L, Williams R, Whealan J, Windels A, Anderson E, Parikh V, et al.
J Cancer Educ
. 2023 Jan;
38(4):1296-1303.
PMID: 36637713
Annual lung cancer screening (LCS) is recommended for individuals at high risk for lung cancer. However, primary care provider-initiated discussions about LCS and referrals for screening are low overall, particularly...
4.
Cao P, Smith L, Mandelblatt J, Jeon J, Taylor K, Zhao A, et al.
JNCI Cancer Spectr
. 2022 Jul;
6(4).
PMID: 35818125
Background: There are limited data on the cost-effectiveness of smoking cessation interventions in lung cancer screening settings. We conducted an economic analysis embedded in a national randomized trial of 2...
5.
Taylor K, Williams R, Li T, Luta G, Smith L, Davis K, et al.
J Natl Cancer Inst
. 2022 Jul;
114(10):1410-1419.
PMID: 35818122
Background: Lung cancer mortality is reduced via low-dose computed tomography screening and treatment of early-stage disease. Evidence-based smoking cessation treatment in the lung screening setting can further reduce mortality. We...
6.
Williams R, Eyestone E, Smith L, Philips J, Whealan J, Webster M, et al.
Curr Oncol
. 2022 Apr;
29(4):2211-2224.
PMID: 35448154
Offering smoking cessation treatment at lung cancer screening (LCS) will maximize mortality reduction associated with screening, but predictors of treatment engagement are not well understood. We examined participant characteristics of...
7.
Williams R, Cordon M, Eyestone E, Smith L, Luta G, McKee B, et al.
Cancer
. 2022 Feb;
128(10):1976-1986.
PMID: 35143041
Background: For patients at high risk for lung cancer, screening using low-dose computed tomography (lung cancer screening [LCS]) is recommended. The purpose of this study was to examine whether screening...
8.
Kim E, Williams R, Eyestone E, Cordon M, Smith L, Davis K, et al.
Contemp Clin Trials
. 2021 May;
106:106429.
PMID: 33964415
Significance: Although it is a requirement that tobacco treatment is offered to cigarette smokers undergoing low-dose computed tomographic lung cancer screening (LCS), not all smokers engage in treatment. To understand...
9.
Cordon M, Eyestone E, Hutchison S, Dunlap D, Smith L, Williams R, et al.
Prev Med Rep
. 2021 Apr;
22:101359.
PMID: 33868901
Older individuals who smoke are at increased risk of having severe outcomes from COVID-19, due to their long-term smoking and underlying health conditions. In this qualitative study, we explored the...
10.
Rakhit S, Nordness M, Lombardo S, Cook M, Smith L, Patel M
Semin Respir Crit Care Med
. 2020 Sep;
42(1):127-144.
PMID: 32916746
Traumatic brain injury (TBI) is the leading cause of death and disability in trauma patients, and can be classified into mild, moderate, and severe by the Glasgow coma scale (GCS)....